Join BIO President and CEO Dr. Michelle McMurry-Health and Kevin
Outterson
 â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â
Â
Problems viewing this email?
View Message In Browser
[link removed]
Â
This week, we have two free virtual events, including a Policy Spotlight
with Michelle McMurry-Heath, President and CEO of Biotechnology
Innovation Organization and a Journal Club with Boston University School
of Law's Kevin Outterson.
View the full series of events and register today
[link removed]
Policy Spotlight: One-on-One Conversation with Michelle McMurry-Heath,
President and CEO, Biotechnology Innovation Organization (BIO)
Date: Friday, November 12, 2021
Time: 1:00 p.m. - 2:00 p.m. Eastern / 10:00 a.m. - 11:00 a.m.
Pacific
You are invited to join Health Affairs Editor-in-Chief Alan Weil when he
welcomes Michelle McMurry-Heath, President and CEO the Biotechnology
Innovation Organization (BIO), for a discussion of current topics in
pharmaceuticals including, but not limited to, reducing barriers to
vaccines and other life-saving technologies, and policy relating to
generics, patents, and prices.
A medical doctor and molecular immunologist by training, Dr.
McMurry-Heath previously held leadership roles at Johnson & Johnson
(J&J), was associate science director of the FDA's Center for Devices
and Radiological Health, and was the founding director of the Aspen
Institute's Health, Biomedical Science, and Society Policy Program.Â
Broadening access to scientific progress so more patients from diverse
backgrounds can benefit from cutting-edge innovation has been a common
thread across her work.
Please email your questions in advance to
[email protected]
and we will make every effort, in the
limited time available, to have them addressed. First priority will be
given to topics relevant to the widest swath of the audience.Â
Register Now
[link removed]
Journal Club: "Estimating The Appropriate Size Of Global Pull Incentives
For Antibacterial Medicines" by Kevin Outterson, Boston University
School of Law
****
Date: Wednesday, November 10, 2021
Time: 3:00 p.m. - 4:00 p.m. Eastern / 12:00 p.m. - 1:00 p.m. Pacific
The centerpiece of the November Health Affairs Journal Club meeting is
"Estimating The Appropriate Size Of Global Pull Incentives For
Antibacterial Medicines." In the paper, to appear in the November 2021
issue of the journal, author Kevin Outterson of the Boston University
School of Law, examines policy initiatives under way in the US and UK
that explore paying for exceptional antibacterials with "pull"
incentives (paid after regulatory approval). The paper lays out a new
model for calculating the global incentives required to create a
functional antibacterial market, and on November 10, Mr. Outterson will
talk in detail about his research, methods, and conclusions.
Register Now
Stay tuned for announcements about additional events. We hope you join
us this November.
Debbie Boylan
Director of Events, Health Affairs
[link removed]
Â
[link removed]
Â
[link removed]
Â
[link removed]
About Health Affairs
Health Affairs is the leading peer-reviewed journal
at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org , Health
Affairs Today , and Health
Affairs Sunday Update . Â
Project HOPE is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.
Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States
Privacy Policy
To unsubscribe from this email, click here
.
_________________
Sent to
[email protected]
Unsubscribe:
[link removed]
Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States
